Harbin Medical University

This study is testing whether combining three different types of drugs—an immunotherapy (camrelizumab), an anti-fibrotic drug (pirfenidone), and chemotherapy—can help control advanced triple-negative breast cancer. The trial will enroll 12 women who have already received first-li…

This study is testing whether a new combination of two drugs can help control advanced colorectal cancer that has stopped responding to standard treatments. It will involve about 18 adults whose cancer has specific immune markers. Participants will receive an intravenous drug eve…

This study is testing a new four-drug combination given before surgery for early, high-risk triple-negative breast cancer (TNBC) with a specific genetic feature called HRD positive. The goal is to see if this combination can shrink or eliminate the tumor before it is surgically r…

This large study aims to see if using a detailed heart scan (coronary CTA) to guide treatment is better than standard care at preventing heart attacks, strokes, and death in high-risk adults in rural China. Nearly 15,000 people aged 40-75 with high cholesterol, diabetes, or kidne…

This study is testing a 6-week mobile app program designed to help parents and caregivers of children with autism. The app uses interactive stories and therapy-based exercises. Researchers want to see if using the app reduces caregivers' stress, anxiety, and feelings of burnout c…